Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
| Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
|---|---|---|---|---|
| Gusev VA et al. | 2005 | bacterium, <i>Escherichia coli</i>/K12 | geomagnetic field, shielding/field deprivation | - |
| Hambarde S et al. | 2023 | intact cell/cell culture, GBM115 (Temozolomide-resistant cell line derived from a glioblastoma patient) | static magnetic field, magnetic field, low frequency, signals/pulses | - |
| Hanini R et al. | 2017 | bacterium, <i>Pseudomonas aeruginosa</i> | static magnetic field | - |
| Hirai T et al. | 2004 | intact cell/cell culture | static magnetic field | 100 mT |
| Hirai T et al. | 2005 | primary hippocampal neuronal cultures | static magnetic field | 100 mT |
| Iwamoto KS et al. | 2021 | intact cell/cell culture, Lewis lung carcinoma (LLC) cells, human glioblastoma cells (U87MG-viii), animal | static magnetic field, co-exposure | - |
| Iwasaki T et al. | 1978 | intact cell/cell culture, CHO (Chinese hamster ovary) cells, slime mold plasmodia (<i>Physarum polycepharum</i>), animal, frog embryos (<i>Xenopus laevis</i>) | static magnetic field, DC | 500 mT |
| Izzo L et al. | 2019 | intact cell/cell culture, SH-SY5Y cells (human neuroblastoma cell line) | static magnetic field | - |
| Jalali A et al. | 2019 | intact cell/cell culture, A2780 (human ovarian carcinoma-sensitive to cisplatin) and A2780-CP (human ovarian carcinoma-resistant to cisplatin) | static magnetic field, also other exposures without EMF, co-exposure | - |
| Javani Jouni F et al. | 2013 | intact cell/cell culture, bone marrow stem cells (rat) | static magnetic field | - |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.
